Tokyo: Life Sciences and Health Care Horizons 2024

Key life sciences issues for Japanese companies

You are warmly invited to join us in Tokyo for the final session in our global Life Sciences and Health Care Horizons series. The event will be held in Hogan Lovells’ Tokyo office on Wednesday, 16 October.

The event series is designed to help participants understand and tackle the issues shaping the future of the industry, for your local market and globally.

Our planned topics include the following:

  • Current life sciences regulatory trends in the U.S. and EU markets: we plan to discuss recent trends, including European Regulatory Data Protection reform, regulatory exclusivities (such as orphan market exclusivity and pediatric rewards), trends in the regulation of biosimilars and biobetters, advancements in the European Health Technology Assessment, as well as how recent legislation such as the U.S. Inflation Reduction Act (IRA) could impact Japanese companies operating in the U.S.
  • Global trends in AI and digital health: we will analyze the latest developments in AI and digital health from a technological and compliance perspective and discuss how these changes are likely to affect Japanese companies in the future.
  • Cross-border licensing transactions in life sciences: we plan to share insights from recent multi-jurisdictional licensing matters to provide strategic advice for Japanese companies involved in cross-border licensing transactions in the U.S., Europe, and Japan. The event will conclude with a networking reception.

There will be ample opportunities for questions, and we will finish with a reception in the evening.


Register your interest here


Back To Listing